AC Immune SA risk profile
74 Stretched several inputs deteriorating together
Measured 1 September 2026 from ACIU's filed statements. Recomputed nightly.
74 (Stretched), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 71 | Stretched | Volatile | One-year price volatility — 76.7% |
| Operating pressure | 80 | Acute | Worsening | Costs outgrowing revenue — +77.8 percentage points |
| Cash conversion | 100 | Acute | Worsening | Capital spending against operating cash — -0.01x |
| Leverage and coverage | 50 | Elevated | Worsening | Interest cover — -354.73x |
| Competitive position | 73 | Stretched | Stable | Operating-margin gap against peers — -1,902.3 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.